The table below shows Inhibrx, Inc.'s income statement line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
Revenue
$1.80M
$2.19M
$7.23M
$12.89M
$13.21M
Cost of revenue
-
-
-
-
-
Gross profit
-
-
-
-
-
R&D
$191.64M
$110.19M
$71.44M
$73.50M
$47.91M
SG&A
$29.38M
$21.12M
$12.36M
$6.84M
$6.26M
INBX annual revenue (10-K history)
Inhibrx, Inc. reported annual revenue of $1.80M for fiscal year 2023. That is down 17.9% from $2.19M in fiscal 2022. Over the 5 fiscal years shown, annual revenue declined from $13.21M (FY 2019) to $1.80M. Figures come from the company's audited annual reports as filed with the SEC.